Its dual mechanism works similarly to tirzepatide (Mounjaro/Wegovy)
A clear blue solution is expected
Researched effects In a diet-induced-obese mouse study (Neelakantan et al., Biochemical Pharmacology, 2018), subcutaneous 5-Amino-1MQ (20 mg/kg, three times daily, roughly 11 days) produced about 5.1% body-weight loss versus continued weight gain in untreated controls, roughly 35% less epididymal white fat mass, smaller adipocytes, lower plasma cholesterol, and improved glucose tolerance, with no reported change in food intake and no observed adverse effects in the mice
By blocking NNMT, 5-Amino-1MQ allows your cells to use energy more efficiently, burn fat faster, and preserve lean muscle mass
Whether 5-Amino-1MQ, a GLP-1, or a combination fits you depends on your labs, your current medications, and your goals exactly the kind of call a provider makes with you, not a website
NAD+ & SIRT1 Support : Facilitates research into increasing intracellular NAD+ levels and subsequent activation of longevity pathways